What is the official website of Lilly Medical US ?

The official website of Lilly Medical US is https://www.lillymedical.com.

What is Lilly Medical US's cybersecurity risk score?

Lilly Medical US has an AI-generated cybersecurity risk score of 760 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Lilly Medical US experienced?

According to Rankiteo, Lilly Medical US currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Lilly Medical US been affected by any supply chain cyber incidents ?

According to Rankiteo, Lilly Medical US has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Lilly Medical US have SOC 2 Type 1 certification ?

According to Rankiteo, Lilly Medical US is not certified under SOC 2 Type 1.

Does Lilly Medical US have SOC 2 Type 2 certification ?

According to Rankiteo, Lilly Medical US does not hold a SOC 2 Type 2 certification.

Does Lilly Medical US comply with GDPR ?

According to Rankiteo, Lilly Medical US is not listed as GDPR compliant.

Does Lilly Medical US have PCI DSS certification ?

According to Rankiteo, Lilly Medical US does not currently maintain PCI DSS compliance.

Does Lilly Medical US comply with HIPAA ?

According to Rankiteo, Lilly Medical US is not compliant with HIPAA regulations.

Does Lilly Medical US have ISO 27001 certification ?

According to Rankiteo,Lilly Medical US is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Lilly Medical US operate in ?

Lilly Medical US operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Lilly Medical US have ?

Lilly Medical US employs approximately None employees people worldwide.

Does Lilly Medical US own any subsidiaries ?

Lilly Medical US presently has no subsidiaries across any sectors.

How many LinkedIn followers does Lilly Medical US have ?

Lilly Medical US's official LinkedIn profile has approximately 26,996 followers.

What is the NAICS classification code for Lilly Medical US ?

Lilly Medical US is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Lilly Medical US have a Crunchbase profile ?

No, Lilly Medical US does not have a profile on Crunchbase.

Does Lilly Medical US have a LinkedIn profile ?

Yes, Lilly Medical US maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/lilly-medical.

How many cybersecurity incidents has Lilly Medical US experienced ?

As of October 12, 2026, Rankiteo reports that Lilly Medical US has not experienced any cybersecurity incidents.

How many peer or competitor companies does Lilly Medical US have ?

Lilly Medical US has an estimated 5,773 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

LMU

Boost Score +25 with badge (5 left)

760

/1000

Fair

785

/1000

Fair

Lilly Medical US Vendor Cyber Rating & Cyber Score

lillymedical.com

Add Your Compliance Badge

Lilly’s official US support channel for medical news, information, and education. Content is intended for US HCPs. General Information and Guidelines: Eli Lilly and Company strives to create informative and engaging online communities that share information in meaningful ways. We welcome and encourage your participation and engagement in thoughtful and respectful discourse. When you engage with Lilly on LinkedIn (and any other of Lilly’s social media channels), you are agreeing to these Community Guidelines in addition to the Terms and Conditions or other legal notices provided by Lilly and those of LinkedIn: https://e.lilly/guidelines If you have any questions about a Lilly therapy or medicine, please contact our customer care line at

LMU

Lilly Medical US CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

LMU Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for LMU

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Lilly Medical US in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Lilly Medical US in 2026.

Incident Types LMU vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Lilly Medical US in 2026.

Incident History - LMU (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Lilly Medical US Subsidiaries

LMU

Pharmaceutical Manufacturing

Website: https://www.lillymedical.com

Company Size: 10,001+ employees

Eli Lilly and CompanyPharmaceutical Manufacturing

Lilly OncologyPharmaceutical Manufacturing

Lilly CanadaPharmaceutical Manufacturing

Lilly EspañaPharmaceutical Manufacturing

LILLY FRANCEPharmaceutical Manufacturing

Lilly CareersPharmaceutical Manufacturing

Loading…

Lilly Medical US Similar Companies

Merck

merck.us

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ

Novartis

novartis.com

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

Torrent Pharmaceuticals Ltd

cb torrentpharma.com

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”

Viatris

viatris.com

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life’s moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India Social Media Guidelines: https://newsroom.viatris.com/social-media-community-guidelines Investors: https://investor.viatris.com Corporate Social Responsibility: https://www.viatris.com/sustainability Connect with Viatris Instagram: https://www.instagram.com/viatrisinc X: https://www.x.com/viatrisinc Viatris and our recruiting firms will not ask for sensitive personal information, such as your social security number, date of birth or bank account details via text, email or social media. Additionally, Viatris representatives do not request payment or personal bank information nor send payment to purchase hardware on your own. Viatris.com is the primary source of all company job postings and authorized third-party career websites.

Johnson & Johnson Innovative Medicine

jnj.com

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK

Grifols

cb linktr.ee

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. People are at the heart of what we do, and we strive to create an inclusive, diverse, fair and equal society. Maintaining and promoting a workforce that reflects this reality leads to enhanced professional relationships and helps us to give our best to patients, donors and customers. In 2024, Grifols was named one of TIME’s ‘World’s Best Companies’ for the second year in a row, reaffirming our commitment to excellence. We were also recognized by Forbes as one of the "Best Employers for Women 2023," reflecting our dedication to fostering an inclusive and supportive workplace for all. To maintain a positive community and overall respectful communication, please keep our community guidelines in mind.

Hikma Pharmaceuticals

cb hikma.com

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 29 manufacturing plants, 3 R&D hubs and c9,500 employees worldwide. *As of December 2025 Subscribe to our channel on YouTube https://youtube.com/@hikmapharmaceuticals5668 For all product information and enquiries, please contact us at [email protected]

MACLEODS PHARMACEUTICALS LTD.

macleodspharma.com

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

Servier

servier.com

Servier is an independent international pharmaceutical group governed by a foundation. With its unique governance model, the Group is committed to therapeutic progress to serve patients and integrates the patient voice at every stage of the medicine life cycle. As a leading global player in cardiology and venous diseases, Servier aims to become a leading innovator in oncology and neurology. Through precision medicine, the Group intends to offer targeted therapeutic solutions for a limited number of rare diseases and invests nearly 20% of its brand-name sales in R&D. Headquartered in France, Servier relies on its more than 20,000 employees and a solid geographic presence with medicines distributed in more than 130 countries. In the 2024/25 financial year, the Group achieved revenues of €6.9 billion. -- To report a suspected adverse event with a Servier drug, please visit servier.com

Loading…

NEWS

Lilly Medical US CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

March 12, 2026 09:01 AM

Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks

Compounded weight-loss drugs that contain vitamin B12 and the ‌main ingredient in Eli Lilly's Zepbound could present health risks to...

Read Article

March 09, 2026 07:00 AM

Global drugmakers rush to boost US presence as tariff threat looms

Global drugmakers are ramping up U.S. manufacturing and stockpiling inventory as the Trump administration considers a 100% tariff on...

Read Article

March 05, 2026 08:00 AM

Eli Lilly launches program to help boost employer coverage of obesity drugs in U.S.

Employers can use Lilly's platform to connect with different third-party program administrators that help manage obesity treatment benefits...

Read Article

January 30, 2026 08:00 AM

Eli Lilly plans $3.5 billion manufacturing plant in Pennsylvania to make next-generation obesity injections

The plant will help make Lilly's experimental drug called retatrutide, which has shown the highest weight loss seen to date in a late-stage...

Read Article

January 29, 2026 08:00 AM

Trump says Eli Lilly to build six US plants

U.S. President Donald Trump said on Thursday that the head of Eli Lilly has told him the pharmaceutical company plans to build six plants in...

Read Article

January 28, 2026 08:00 AM

US names HIV, arthritis drugs for next Medicare price talks

The U.S. government on Tuesday named the 15 new drugs targeted for Medicare price negotiations for 2028, including Gilead Sciences' HIV drug...

Read Article

January 22, 2026 08:00 AM

Eli Lilly’s security head on how AI helps, hurts cybersecurity

The trillion-dollar biopharma is balancing innovation with caution.

Read Article

December 24, 2025 08:00 AM

US health agency unveils weight-loss drug coverage model

Dec 23 (Reuters) - The U.S. Centers for Medicare and Medicaid Services on Tuesday unveiled a voluntary program to cover GLP-1 drugs for...

Read Article

December 10, 2025 08:00 AM

Eli Lilly to Build $6 Billion Alabama Plant as Part of U.S. Investment

The site is the third of four new facilities in the U.S. that the pharmaceutical company plans to announce.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-108773

SUMMARY

A vulnerability was detected in erzhongxmu JEEWMS up to 2026.09.27-W39. Impacted is the function docheck of the file src/main/java/com/zzjee/wm/controller/WmOmNoticeHController.java. Performing a manipulation of the argument goodscode results in sql injection. The attack may be initiated remotely. The exploit is now public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-10-11

Updated

Date2026-10-11

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-108772

SUMMARY

A security vulnerability has been detected in bleenco abstruse up to 2.1.0. This issue affects the function filepath.Join of the file server/api/worker/download_cache.go of the component Cache Endpoint. Such manipulation of the argument File leads to path traversal. The attack can be launched remotely. The exploit has been disclosed publicly and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-10-11

Updated

Date2026-10-11

RISK INFORMATION (Score: 5.3)

cvss2

Base Score: 5.0

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:N/A:N

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

3.9

REFERENCES

CVE-2026-108770

SUMMARY

A weakness has been identified in Appwrite up to 2.3.0. This vulnerability affects the function PublicHostname of the file src/Appwrite/Platform/Modules/Avatars/Http/Screenshots/Get.php of the component Browser Screenshot Service. This manipulation of the argument url causes server-side request forgery. The attack can be initiated remotely. Upgrading to version 2.4.0 is able to resolve this issue. Patch name: 393255e7302ae5503331d45802e2eee01c6a47fe. You should upgrade the affected component.

Published

Date2026-10-11

Updated

Date2026-10-11

RISK INFORMATION (Score: 5.3)

cvss2

Base Score: 5.0

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:N/A:N

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

3.9

REFERENCES

CVE-2026-108978

SUMMARY

Heap-based buffer overflow vulnerability in Samsung Opensource rlottie allows Buffer Overflow via Environment Variables. This issue affects rlottie: e57b094f03c39a751a1fded6f7d6c13f1ed95ec9.

Published

Date2026-10-11

Updated

Date2026-10-11

RISK INFORMATION (Score: 5.5)

cvss3

Base Score: 5.5

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

1.8

REFERENCES

https://github.com/Samsung/rlottie/pull/609/

CVE-2026-108769

SUMMARY

A security flaw has been discovered in zhayujie CowAgent up to 2.2.0. This affects an unknown part of the file Markdown.tsx of the component Markdown Rendering. The manipulation results in denial of service. It is possible to launch the attack remotely. The exploit has been released to the public and may be used for attacks. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-10-11

Updated

Date2026-10-11

RISK INFORMATION (Score: 4.3)

cvss2

Base Score: 4.0

Complexity: LOW

AV:N/AC:L/Au:S/C:N/I:N/A:P

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Lilly Medical US Vendor Cyber Rating & Cyber Score

LMU A.I CyberSecurity Scoring

Lilly Medical US CyberSecurity News & History

LMU Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for LMU

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types LMU vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - LMU (X = Date, Y = Severity)

Lilly Medical US Subsidiaries

LMU

Lilly Medical US Similar Companies

Merck

Novartis

Torrent Pharmaceuticals Ltd

Viatris

Johnson & Johnson Innovative Medicine

Grifols

Hikma Pharmaceuticals

MACLEODS PHARMACEUTICALS LTD.

Servier

Lilly Medical US CyberSecurity News

Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks

Global drugmakers rush to boost US presence as tariff threat looms

Eli Lilly launches program to help boost employer coverage of obesity drugs in U.S.

Eli Lilly plans $3.5 billion manufacturing plant in Pennsylvania to make next-generation obesity injections

Trump says Eli Lilly to build six US plants

US names HIV, arthritis drugs for next Medicare price talks

Eli Lilly’s security head on how AI helps, hurts cybersecurity

US health agency unveils weight-loss drug coverage model

Eli Lilly to Build $6 Billion Alabama Plant as Part of U.S. Investment

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Lilly Medical US CyberSecurity News & History

LMU Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for LMU

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types LMU vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - LMU (X = Date, Y = Severity)

Lilly Medical US Subsidiaries

LMU

Lilly Medical US Similar Companies

Merck

Novartis

Torrent Pharmaceuticals Ltd

Viatris

Johnson & Johnson Innovative Medicine

Grifols

Hikma Pharmaceuticals

MACLEODS PHARMACEUTICALS LTD.

Servier

Lilly Medical US CyberSecurity News

Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks

Global drugmakers rush to boost US presence as tariff threat looms

Eli Lilly launches program to help boost employer coverage of obesity drugs in U.S.

Eli Lilly plans $3.5 billion manufacturing plant in Pennsylvania to make next-generation obesity injections

Trump says Eli Lilly to build six US plants

US names HIV, arthritis drugs for next Medicare price talks

Eli Lilly’s security head on how AI helps, hurts cybersecurity

US health agency unveils weight-loss drug coverage model

Eli Lilly to Build $6 Billion Alabama Plant as Part of U.S. Investment

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo